Prevention of Arrhythmia Device Infection Trial (PADIT)
Prevention of Arrhythmia Device Infection Trial (PADIT) Cluster Crossover Study
Sponsor: Canadian Institutes of Health Research (CIHR)
Listed as NCT01628666, this PHASE4 trial focuses on Arrhythmia and remains completed. Sponsored by Canadian Institutes of Health Research (CIHR), it has been updated 7 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jul 2019 — Jan 2021 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Oct 2018 — Jul 2019 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
First recorded
Dec 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Institutes of Health Research (CIHR)
- Population Health Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .